Invention Grant
- Patent Title: Sustained-release triptan compositions and method of use the same through subdermal route or the like
-
Application No.: US16766127Application Date: 2018-12-21
-
Publication No.: US11406628B2Publication Date: 2022-08-09
- Inventor: Keelung Hong , Hao-Wen Kao , Yi-Yu Lin
- Applicant: Taiwan Liposome Co., Ltd , TLC Biopharmaceuticals, Inc.
- Applicant Address: TW Taipei; US CA South San Francisco
- Assignee: Taiwan Liposome Co., Ltd,TLC Biopharmaceuticals, Inc.
- Current Assignee: Taiwan Liposome Co., Ltd,TLC Biopharmaceuticals, Inc.
- Current Assignee Address: TW Taipei; US CA South San Francisco
- Agency: Leason Ellis LLP
- International Application: PCT/US2018/067315 WO 20181221
- International Announcement: WO2019/126766 WO 20190627
- Main IPC: A61K31/454
- IPC: A61K31/454 ; A61K9/127 ; A61K31/4025 ; A61K31/404 ; A61K31/4196 ; A61K31/422 ; A61K47/28
Abstract:
Provided is a sustained-release triptan composition as a suitable depot formulation to carry a therapeutically effective amount of triptan for administration via subcutaneous or intramuscular injection. This sustained-release triptan composition is characterized by a high drug to phospholipid ratio and provides an improved pharmacokinetic profile in vivo. The sustained-release triptan composition is for use as a medicament in the treatment of migraine or cluster headache.
Public/Granted literature
- US1694868A Motor support Public/Granted day:1928-12-11
Information query
IPC分类:
